Header

UZH-Logo

Maintenance Infos

Brief Report: Does Menopause Transition Influence Viral Suppression and Adherence in Women Living With HIV?


Hachfeld, Anna; Atkinson, Andrew; Stute, Petra; Calmy, Alexandra; Tarr, Philip E; Darling, Katharine E A; Babouee Flury, Baharak; Polli, Christian; Sultan-Beyer, Leila; Abela, Irene A; Aebi-Popp, Karoline; Swiss HIV Cohort Study (SHCS) (2023). Brief Report: Does Menopause Transition Influence Viral Suppression and Adherence in Women Living With HIV? Journal of Acquired Immune Deficiency Syndromes, 92(5):399-404.

Abstract

BACKGROUND: Increasing numbers of women living with HIV transition through menopause. It is unclear whether this transition has an impact on treatment adherence, viral suppression, psychiatric comorbidities, or drug use. We aimed at examining adherence and viral suppression during the perimenopausal period and explored the influence of psychiatric comorbidities and active injection drug use (IDU).

SETTING: Retrospective Swiss HIV Cohort Study analysis from January 2010 to December 2018.

METHODS: We explored perimenopausal and postmenopausal trends of viral blips, low-level viremia, viral failure, adherence, psychiatric comorbidities, and IDU using interrupted time series models.

RESULTS: Rates of depression and psychiatric care increased during perimenopause before decreasing afterward. Negative treatment outcomes such as viral blips, low-level viremia, viral failure, and low adherence steadily declined while transitioning through menopause-this was also true for subgroups of women with depression, psychiatric treatment, and active IDU.

CONCLUSIONS: Increased rates of depression and psychiatric care while transitioning through menopause do not result in lower rates of adherence or viral suppression in women living with HIV in Switzerland.

Abstract

BACKGROUND: Increasing numbers of women living with HIV transition through menopause. It is unclear whether this transition has an impact on treatment adherence, viral suppression, psychiatric comorbidities, or drug use. We aimed at examining adherence and viral suppression during the perimenopausal period and explored the influence of psychiatric comorbidities and active injection drug use (IDU).

SETTING: Retrospective Swiss HIV Cohort Study analysis from January 2010 to December 2018.

METHODS: We explored perimenopausal and postmenopausal trends of viral blips, low-level viremia, viral failure, adherence, psychiatric comorbidities, and IDU using interrupted time series models.

RESULTS: Rates of depression and psychiatric care increased during perimenopause before decreasing afterward. Negative treatment outcomes such as viral blips, low-level viremia, viral failure, and low adherence steadily declined while transitioning through menopause-this was also true for subgroups of women with depression, psychiatric treatment, and active IDU.

CONCLUSIONS: Increased rates of depression and psychiatric care while transitioning through menopause do not result in lower rates of adherence or viral suppression in women living with HIV in Switzerland.

Statistics

Citations

Dimensions.ai Metrics
2 citations in Web of Science®
3 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

5 downloads since deposited on 06 Nov 2023
5 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Infectious Diseases
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Infectious Diseases
Health Sciences > Pharmacology (medical)
Language:English
Date:15 April 2023
Deposited On:06 Nov 2023 12:38
Last Modified:29 Jun 2024 01:39
Publisher:Lippincott Williams & Wilkins
ISSN:1525-4135
OA Status:Hybrid
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1097/QAI.0000000000003158
PubMed ID:36595226
  • Content: Published Version
  • Language: English
  • Licence: Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)